Q3 2025 Earnings Call Transcript October 30, 2025 DexCom, Inc. beats earnings expectations. Reported EPS is $0.61, ...

DexCom (DXCM) is forecasting robust earnings growth of 19.2% per year and revenue growth of 11.8% per year. Both figures outpace the broader US market’s revenue growth forecast of 10.4%. Over the past ...

Medical device company DexCom (NASDAQ:DXCM) will be reporting results this Thursday after market close. Here’s what you need ...

Dexcom is facing scrutiny and class-action lawsuits over alleged safety and accuracy issues with its G7 monitor.

Thank you, operator, and welcome to DexCom's Third Quarter 2025 Earnings Call. Our agenda begins with Jake Leach, DexCom's President and Interim CEO, who will summarize our recent highlights and ...

December S&P 500 E-Mini futures (ESZ25) are up +0.42%, and December Nasdaq 100 E-Mini futures (NQZ25) are up +0.57% this ...

DexCom, Inc. DXCM reported third-quarter 2025 adjusted earnings per share (EPS) of 61 cents, which beat the Zacks Consensus ...

DexCom, Inc. DXCM is scheduled to report third-quarter 2025 resultson Oct. 30, after the closing bell. In the last reported ...

Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) fell 6% in the afternoon session after investor ...

The DJS Law Group  reminds investors of a class action lawsuit against  Marex Group plc ("Marex" or "the Company") for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule ...

Santiago/ The smartwatch market continues to evolve rapidly, building on the impressive innovations seen in 2025. As more ...

The AI health companion unifies data from wearables and habits across sleep, fitness, and nutrition into personalized ...